Buch

Trilling T (Hrsg), Graf (Dippel) M, Borowy O, Knoke C. Pharmamarketing - Ein Leitfaden für die tägliche Praxis Fachbuch, Springer – Verlag Berlin, Heidelberg, New York, Neuauflage 2008;


Publikationen aus eigener wissenschaftlicher Arbeit

Graf (Dippel) M, Stein D, Bauer CP Wirksamkeit von Montelukast und DNCG beim excise-induced Asthma in Abhängigkeit von der Asthmaform. Monatszeitschrift Kinderheilkunde 2001 (3)


Graf (Dippel) M, Danhauser-Riedl S, Reif S, Schoch C, Schnittger S, Haferlach T, Hiddemann W, Nüssler V, Schmetzer H. Expression of adhesion molecules and costimulatory antigens in acute myeloid leukemia Blood, 2001, 98 (suppl.2): Nr. 4445


Graf (Dippel) M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Nuessler V, Schmetzer H: Low l-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk Europ. J. Haematol 2003 : 71: 366-376


Graf (Dippel) M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Nuessler V, Schmetzer H Expression and prognostic Value of hemopoietic cytokine receptors in Acute myeloid leukemia (AML): Implications for future therapeutical strategies. Eur J Haematol. 2004 Feb;72(2):89-106


Graf (Dippel) M, Reif S, Hecht K, Pelka-Fleischer R, Kroell T, Pfister K, Schmetzer H. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML). Ann Hematol. 2005 May;84(5):287-97.


Graf (Dippel) M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Schmetzer H. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis. Am J Hematol. 2005 May;79(1):26-35.


Graf (Dippel) M, Reif S, Hecht K, Kroell T, Nuessler V, Schmetzer H. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies. Eur J Haematol. 2005 Dec;75(6):477-84.


Graf (Dippel) M, Reif S, Kroll T, Hecht K, Nuessler V, Schmetzer H. Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis. Am J Hematol. 2006 Apr;81(4):227-35.


Steiner K, Graf (Dippel) M, Hecht K, Reif S, Rossbacher L, Pfister K, Kolb HJ, Schmetzer HM, Multhoff G. High HSP70-membrane expression on leukemic cells from patients with acute myeloid leukemia is associated with a worse prognosis. Leukemia 2006 Nov;20(11):2076-9.


Petrovici K, Graf (Dippel) M, Hecht K, Reif S, Pfister K, Schmetzer H. Use of NG2 (7.1) in AML as a tumor marker and its association with a poor prognosis. Cancer Genomics Proteomics. 2010 Jul-Aug;7(4):173-80.


Petrovici K, Graf (Dippel) M, Reif S, Hecht K, Schmetzer HM: Expression Profile of the Progenitor Cell Markers CD34, CD38 and CD90 in Acute Myeloid Leukemia and Their Prognostic Significance. J Cancer Mol 2010; 5(3): 79-86.